Skin tolerance, efficacy, and quality of life of patients with red facial skin using a skin care regimen containing Licochalcone A

Journal of Cosmetic Dermatology

Volumn 5, Issue 3, 2006, Pages 227-232

  Weber, T M ^a   Ceilley, R I ^b   Buerger, A ^c   Kolbe, L ^c   Trookman, N S ^d   Rizer, R L ^e   Schoelermann, A ^c  

^a Beiersdorf Inc   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c BEIERSDORF AG   (Germany)

^d Rocky Mountain Laser Center   (United States)

^e Thomas J Stephens and Associates   (United States)

Author keywords

Erythema; Inflammation; Quality of life; Rosacea

Indexed keywords

LICOCHALCONE A; METRONIDAZOLE;

ADULT; AGED; ARTICLE; BURN; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; GLYCYRRHIZA; GLYCYRRHIZA INFLATA; HUMAN; PHOTOGRAPHY; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; QUESTIONNAIRE; ROSACEA; SCORING SYSTEM; SKIN CARE; SKIN IRRITATION; SKIN REDNESS; SKIN SENSITIVITY; SKIN TIGHTNESS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADULT; AGED; CHALCONES; DRUG THERAPY, COMBINATION; ERYTHEMA; FACE; FEMALE; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; QUALITY OF LIFE; ROSACEA; SKIN CARE; TREATMENT OUTCOME;

EID: 33748148704     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2006.00261.x     Document Type: Article

References (19)

1. Gupta AK, Chaudhry MM. Rosacea and its management: An overview. J Eur Acad Dermatol Venered 2005; 19: 273-85.
2. Buechner S. Rosacea: An update. Dermatology 2005; 210: 100-8.
3. Ceilley RI. Advances in the topical treatment of acne and rosacea. J Drugs Dermatol 2004; 3: S12-22.
4. Crawford GH, Pelle MT, James WD, Rosacea. I. Etiology, pathogenesis, and subtye classification. J Am Acad Dermatol 2004; 51: 327-41.
5. Wilkin J, Dahl M, Detmar M et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002; 46: 584-7.
6. Wilkin J, Dahl M, Detmar M et al. Standard grading system for rosacea. Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2004; 50: 907-12.
7. Millikan L. Recognizing rosacea. Postgrad Med 1999; 105: 149-58.
8. Draelos ZD. Facial hygiene and comprehensive management of rosacea. Cutis 2004; 73: 183-7.
9. Draelos ZD. Treating beyond the histology of rosacea. Cutis 2004; 74: 28-31.
10. Del Rosso JQ. Adjunctive skin care in the management of rosacea: cleansers, moisturizers, and photoprotectants. Cutis 2005; 75: 17-21.
11. Frampton JE, Wagstaff AJ. Azelaic acid 15% gel in the treatment of papulopustular rosacea. Am J Clin Dermatol 2004; 5: 57-64.
12. McClellan KJ, Noble S. Topical metronidazole. A review of its use in rosacea. Arch Dermatol 1987; 123: 609-14.
13. Pelle MT, Crawford GH, James WD. Rosacea: II. Therapy. J Am Acad Dermatol 2004; 51: 499-512.
14. Bikowski JB. The pharmacologic therapy of rosacea: A paradigm shift in progress. Cutis 2005; 75: 27-32.
15. Holme SA, Beattie PE, Fleming CJ. Cosmetic camouflage advice improves quality of life. Br J Dermatol 2002; 147: 946-9.
16. Dieck K, Immeyer J, Wolber R, Weber TM, Kolbe L. Anti-inflammatory properties of licochalcone A from Glycyrrhiza inflata on various human skin cells. J Am Acad Dermatol 2005; 52: P97 (Poster 1055).
17. Kolbe L, Immeyer J, Batzer J et al. Anti-inflammatory efficacy of licochalcone A: Correlation of anti-irritative clinical potency and in vitro effects. Arch Dermatol Res 2006; 298: 23-30.
18. Immeyer J, Batzer J, Wolber R, Weber TM, Kolbe L. Anti-irritant efficacy of Licochalcone A-containing formulations on razor and UV-induced skin irritation. J Am Acad Dermatol 2005; 52: P85 (Poster 1007).
19. Weber T, Schoelermann A, Buerger A, Rizer R. Tolerance and efficacy of a skin care regimen containing licochalcone A with erythematous rosacea and facial redness. J Am Acad Dermatol 2005; 52: P95 (Poster 1046).